Sign Up Today and Learn More About HighTide Therapeutics Stock
Invest in or calculate the value of your shares in HighTide Therapeutics or other pre-IPO companies through EquityZen's platform.
HighTide Therapeutics Stock
HighTide Therapeutics is a global clinical-stage biopharmaceutical company.
About HighTide Therapeutics Stock
Founded
2011
Industries
Software, Data and Analytics, Artificial Intelligence
HighTide Therapeutics Press Mentions
Stay in the know about the latest news on HighTide Therapeutics
HighTide Therapeutics on LinkedIn: #mash
linkedin • May 20, 2024
Chinese biotech firm HighTide Therapeutics slashes Hong Kong IPO size by 80% to US$35.6 million
finance • Feb 11, 2024
Updated: Metabolic drug developer HighTide Therapeutics eyes $36M raise with HK IPO
endpts • Dec 16, 2023
HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study)
biopharmaapac • Jan 25, 2023
American Journal of Gastroenterology Publishes Data from HighTide Therapeutics' Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
biospace • Jan 25, 2023
HighTide Therapeutics Management
Leadership team at HighTide Therapeutics
Senior VP / Global Head, DMPK and Clinical Pharmacology
Jin Chen
Chief Product Development Officer & MD
Steven E. Linberg
Join now and verify your accreditation status to gain access to:
- HighTide Therapeutics current valuation
- HighTide Therapeutics stock price
- Available deals in HighTide Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in HighTide Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like HighTide Therapeutics through EquityZen funds. These investments are made available by existing HighTide Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell HighTide Therapeutics stock?
Shareholders can sell their HighTide Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
